Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica
April 02, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Key Regional Health Plan Further Expands Number of Covered Lives to Over 280 Million PARSIPPANY, NJ, April 02, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced...
Interpace Diagnostics Group Reports Full Year and Fourth Quarter 2018 Financial Results
March 19, 2019 16:05 ET
|
Interpace Diagnostics Group, Inc.
Business Progress and Recent Accomplishments Highlighted and Discussed Further on Conference Call PARSIPPANY, NJ, March 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:...
Interpace Diagnostics Announces Preliminary 2018 Revenues
February 28, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Interpace to Host Fourth Quarter and Full Year 2018 Results Conference Call/Webcast PARSIPPANY, NJ, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock
January 29, 2019 16:20 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the closing of its previously announced...
Interpace Diagnostics Announces Proposed Public Offering of Common Stock
January 24, 2019 16:35 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) announced today that it intends to offer and sell shares of its...
Interpace Diagnostics to Present at the Fifteenth Annual NobleCon
January 24, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced that Jack Stover, Chief Executive Officer, will present at NobleConXV - Noble Capital...
Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing
November 07, 2018 06:55 ET
|
Interpace Diagnostics Group, Inc.
The Federal Employee Health Benefit BCBS Program Adds Approximately 5.3 Million Covered Lives PARSIPPANY, NJ, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results on Tuesday, November 13, 2018
November 06, 2018 06:55 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it will report its third quarter 2018 financial results after the close of...
Interpace Diagnostics Presents Favorable New Data at the 88th Annual Meeting of the American Thyroid Association (ATA)
October 15, 2018 06:55 ET
|
Interpace Diagnostics Group, Inc.
ThyGenX® and ThyraMIR® Data from Clinical Experience Study Shows Positive Results PARSIPPANY, NJ, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced that...
Interpace Diagnostics Enters into Agreement with Renowned Integrated Health System
October 04, 2018 06:55 ET
|
Interpace Diagnostics Group, Inc.
Agreement with Piedmont Healthcare Covers Company’s Pancreatic Cancer Test PARSIPPANY, NJ, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) reported today that it has...